Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'

Br J Cancer. 2018 Feb 6;118(3):e1. doi: 10.1038/bjc.2017.342. Epub 2017 Nov 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Neoplasm Recurrence, Local / radiotherapy
  • Prostatic Neoplasms / radiotherapy*
  • Radiosurgery*